{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreihmvqlioeaznmskrt4vhcniwi2gfn2pskzpwuwdj5wz5rg5gp2s7e",
    "uri": "at://did:plc:pmmp7irwts7faw56jdxk3idc/app.bsky.feed.post/3mgo3yuds7j22"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreiaazzwlz6me5aja723wlgzpwadgad6n3ekua3vq4qb3bebxfvugte"
    },
    "mimeType": "image/jpeg",
    "size": 394741
  },
  "path": "/news/2026-03-hidden-blood-mutations-severe-inflammatory.html",
  "publishedAt": "2026-03-09T18:40:03.000Z",
  "site": "https://medicalxpress.com",
  "textContent": "Indiana University School of Medicine scientists have uncovered new evidence that an age-related blood condition may contribute to inflammatory bowel disease (IBD). Their findings suggest that a new drug strategy targeting the blood condition may reduce IBD severity, and offer a new path for treating chronic diseases like Crohn's disease and ulcerative colitis.",
  "title": "Hidden blood mutations drive severe inflammatory bowel disease, but a new treatment target is in sight"
}